News

UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain.

A UCSF study of human and mouse pancreatic tissue suggests a new origin story for type 1 diabetes.

A program offering group support, acupuncture, mindfulness, massage and gentle exercise may help prevent patients on prescription opioids from spiraling down to drug misuse, overdose and death.

Ronald D. Vale, PhD, professor of cellular and molecular pharmacology at UCSF, has been named executive director of the Janelia Research Campus of the Howard Hughes Medical Institute and an HHMI vice president, effective in early 2020.

The gift established the endowed Jere E. Goyan Presidential Chair for the Advancement of Pharmacy, which honors the longest-serving dean of the School of Pharmacy.

UCSF scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally “invisible” to the immune system.

The Health Innovation Via Engineering program will be led by Tejal Desai.

A personal survey of patients with AF has found that the majority of triggers for the condition are easily modifiable lifestyle choices, including alcohol, caffeine, exercise and lack of sleep.

UCSF Fresno recently received contributions of more than $1 million from two development companies and families known for giving back to the local community.

UCSF researchers created a chimpanzee brain “organoids” that mimic the development and organization of full-size brains. 

Scientists at UCSF, in collaboration with colleagues at UNC, have developed the world’s largest virtual pharmacology platform and shown it is capable of identifying extremely powerful new drugs.

Hana El-Samad’s research may one day make it possible to take a broken cell and bring it back to health by dynamically sensing its pathology and fixing it.

The Vilcek Foundation awards prizes each year to “emerging immigrant artists and scientists who have shown exceptional promise early in their career.”

The first recipient of QBI's Scholarship for Women from Developing Nations in Biosciences returns to Uganda with tools for success.

The Resource Allocation Program, in partnership with many on-campus sources of research funding, facilitates the dissemination, submission, review and award of intramural research funding opportunities on campus.

UCSF researchers have for the first time transformed human stem cells into mature insulin-producing cells, a major breakthrough in the effort to develop a cure for type 1 (T1) diabetes.

As a program investigator, James Fraser will receive $1.25 million over the next five years to support his research and teaching.

"Brain health” dietary supplements are “pseudomedicine” and health care providers should discourage patients from pursuing them, say neurologists at UCSF, in a JAMA opinion piece.

Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UCSF has found. 

UCSF's Thea Tlsty, PhD, is a winner of the “Grand Challenge” competition sponsored by Cancer Research UK. Her international team will receive $26 million to uncover how chronic inflammation causes cancer.